NeuroScientific Biopharmaceuticals Ltd

[On Demand]
Search General Info
Search Education
Search Partnering Companies
NeuroScientific Biopharmaceuticals Ltd is an Australian public listed company (ASX:NSB) focused on developing novel peptide-based drugs which have the potential to treat neurodegenerative conditions. NSB’s lead peptide candidate has been shown to induce the survival and regeneration of neurons through binding to specific receptors expressed by neuronal cells. Our therapeutic peptide offers a novel treatment pathway for neurodegenerative condition that are currently without effective treatment options, such as Alzheimer’s disease. Our current R&D program includes indications for neurological conditions and ocular conditions (specific to degeneration of the optic nerve). The company is schedule to transition both programs from preclinical to clinical development in 2021.
Ticker:
NSB
Exchange:
ASX
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Australia
Year Founded:
2016
Main Therapeutic Focus:
Lead Product in Development:
EmtinB - LRP1 agonist
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
photo
CEO & Managing Director
Neuroscientific Biopharmaceuticals Ltd